Palvella Therapeutics, Inc. Common Stock (PVLA)
PHARMACEUTICAL PREPARATIONS
Palvella Therapeutics, Inc. Common Stock (PVLA) is listed on Nasdaq, where it has traded since December 16, 2024.
- Listed On
- Nasdaq
- Listed Since
- December 16, 2024
- Employees
- 29
- Market Cap
- $2.1B
About Palvella Therapeutics, Inc. Common Stock
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 191 institutions reported holding PVLA, with 14.1 million shares worth $2.1 billion in aggregate. The largest reported holder was Suvretta Capital Management, with 1.1 million shares worth $173.5 million. Of the 5 largest holders listed below, 2 added shares, 2 reduced their positions and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Suvretta Capital Management | 1,135,406 | $174M | Reduced 1.57% |
| Jennison Associates | 960,619 | $147M | Added 49.95% |
| BlackRock | 918,357 | $140M | Added 33.71% |
| Frazier Life Sciences Management | 882,400 | $135M | Unchanged |
| First Light Asset Management | 771,901 | $118M | Reduced 21.3% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is PVLA?
Palvella Therapeutics, Inc. Common Stock (PVLA) is listed on Nasdaq, where it has traded since December 16, 2024.
Who are the largest institutional holders of PVLA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of PVLA were Suvretta Capital Management, Jennison Associates and BlackRock.
How many institutions own PVLA?
191 institutions reported a position in PVLA for the quarter ended June 30, 2026, worth $2.1 billion in total.
Did institutions buy or sell PVLA last quarter?
Of the 5 largest reported holders, 2 added shares, 2 reduced their positions and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for PVLA.
Every reported institutional holder, plus insider and congressional trades in PVLA, on SentiSense.